Trials / Completed
CompletedNCT03424577
A Study to Evaluate the Food-Effect of H3B-6527
A Randomized Phase 1 Food-Effect Study of H3B-6527 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- Eisai Inc. · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study will be conducted to determine the effect of food on the relative bioavailability of H3B-6527 following administration of a H3B-6527 capsule with and without a meal.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | H3B-6527 | Oral capsule |
Timeline
- Start date
- 2017-12-27
- Primary completion
- 2018-01-27
- Completion
- 2018-01-27
- First posted
- 2018-02-07
- Last updated
- 2018-02-07
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03424577. Inclusion in this directory is not an endorsement.